|This activity is a post-event, archived electronic newspaper to summarize the conclusions of the live symposium, AOTC: Ahead of the Curve CF Summit. |
|Dates: ||7/22/2011- 7/21/2013 |
|Format: ||Monograph |
|Location: ||Available Online |
|Location Address: || |
|Tuition: ||$0 |
|Who should attend: ||Pulmonologists, pediatric pulmonologists, gastroenterologists, pediatricians, infectious disease specialists, respiratory therapists, dieticians, nutritionists, pharmacists, nurse and nurse practitioners, physical therapists, social workers and other. |
After completing this activity, the participant will demonstrate the ability to:
- Evaluate how increased screening can improve pediatric and adult patient outcomes with current therapies and how those who are newly screened may be affected by approval of CFTR modulators.
- Integrate this information into current clinical practice to more effectively advise and counsel patients, manage patient expectations, and improve quality of life for the pediatric and adult patient.
- Discuss best practices for treating infectious processes in CF patients.
- Describe how the pre-symptomatic diagnosis of children alters approach therapy.
- Detail the differences in prophylactic use of therapies vs. symptomatic care.
- Develop more efficacious individual care plans for pediatric and adult patients.
- Evaluate international disease modifying therapies that affect CFTR.
- Review the novel therapies on the horizon.
- Describe and discuss currently successful CF adherence improvement model.
- Analyze how the pending approval of CFTR modulating therapies may impact adherence.
Upon completion of the post-test, please take a moment to respond to our program evaluation.
|This 0.5 contact hour Educational Activity (which includes 0 hours of pharmacology) is provided by The Institute for Johns Hopkins Nursing. |